Published in J Hepatol on December 01, 1999
Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors. Cold Spring Harb Symp Quant Biol (2005) 2.18
Activation of stem cells in hepatic diseases. Cell Tissue Res (2007) 1.59
Treatment with 2-AAF blocks the small hepatocyte-like progenitor cell response in retrorsine-exposed rats. J Hepatol (2007) 1.57
Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol (2001) 1.17
A growth-constrained environment drives tumor progression invivo. Proc Natl Acad Sci U S A (2001) 1.11
Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08
Hepatic differentiation of amniotic epithelial cells. Hepatology (2011) 0.99
Bmi1 is required for hepatic progenitor cell expansion and liver tumor development. PLoS One (2012) 0.93
Differential growth: from carcinogenesis to liver repopulation. Am J Pathol (2000) 0.90
A critical role for matrix metalloproteinases in liver regeneration. J Surg Res (2008) 0.87
Epithelial cells with hepatobiliary phenotype: is it another stem cell candidate for healthy adult human liver? World J Gastroenterol (2007) 0.81
Clearance of senescent hepatocytes in a neoplastic-prone microenvironment delays the emergence of hepatocellular carcinoma. Aging (Albany NY) (2014) 0.81
Leptin increases mitotic index and regeneration ratio in hepatectomized rats. Med Sci Monit Basic Res (2013) 0.80
Activation of inactive hepatocytes through histone acetylation: a mechanism for functional compensation after massive loss of hepatocytes. Am J Pathol (2011) 0.80
Engraftment of syngeneic and allogeneic endothelial cells, hepatocytes and cholangiocytes into partially hepatectomized rats previously treated with mitomycin C. Transplantation (2009) 0.80
Effects of retrorsine on mouse hepatocyte proliferation after liver injury. World J Gastroenterol (2006) 0.79
Stem cell therapy for inherited metabolic disorders of the liver. Exp Hematol (2008) 0.79
Rodent animal models for surrogate analysis of cell therapy in acute liver failure. Front Physiol (2012) 0.78
Polyploidization without mitosis improves in vivo liver transduction with lentiviral vectors. Hum Gene Ther (2013) 0.77
Recent progress in histochemistry and cell biology. Histochem Cell Biol (2012) 0.76
Comfrey (Symphytum Officinale. l.) and Experimental Hepatic Carcinogenesis: A Short-term Carcinogenesis Model Study. Evid Based Complement Alternat Med (2007) 0.75
The growth pattern of transplanted normal and nodular hepatocytes. Histochem Cell Biol (2011) 0.75
Endogenous and transplanted small hepatocytes in retrorsine-treated/partially hepatectomized rat liver show differences in growth, phenotype, and proximity to clusters of gamma-glutamyl transpeptidase-positive host hepatocytes. J Histochem Cytochem (2009) 0.75
Hyperplasia vs hypertrophy in tissue regeneration after extensive liver resection. World J Gastroenterol (2017) 0.75
Potential applications for cell regulatory factors in liver progenitor cell therapy. Int J Biochem Cell Biol (2010) 0.75
Proliferation of L02 human hepatocytes in tolerized genetically immunocompetent rats. World J Gastroenterol (2008) 0.75
Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol (1998) 2.62
Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest (1987) 1.82
Diminished response to cytotoxic therapy in G-6-PD deficiency. Lancet (1980) 1.39
Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J (1978) 1.31
Neural correlates of cognitive control of reaching movements in the dorsal premotor cortex of rhesus monkeys. J Neurophysiol (2011) 1.29
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Hepatic cholesterol in lead nitrate induced liver hyperplasia. Chem Biol Interact (1984) 1.26
Liver tumour promotion by chemicals: models and mechanisms. Cancer Surv (1986) 1.25
Initiation of chemical carcinogenesis requires cell proliferation. Nature (1978) 1.25
Liver regeneration and alpha-fetoprotein messenger RNA expression in the retrorsine model for hepatocyte transplantation. Cancer Res (1998) 1.24
Proliferation and differentiation of fetal liver epithelial progenitor cells after transplantation into adult rat liver. Am J Pathol (2000) 1.20
Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer (1994) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Effect of dietary tryptophan on hepatic polyribosomes and protein synthesis in fasted mice. J Biol Chem (1968) 1.19
Role of acute hepatic necrosis in the induction of early steps in liver carcinogenesis by diethylnitrosamine. Cancer Res (1981) 1.17
Cycloheximide, an inhibitor of peptide chain termination or release in liver in vivo and in vitro. Biochem Biophys Res Commun (1971) 1.17
Principles of therapeutic liver repopulation. Semin Liver Dis (1999) 1.17
Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol (2001) 1.17
Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res (1981) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
WNT4 deficiency--a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report. Hum Reprod (2006) 1.13
Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J Virol (2001) 1.11
A growth-constrained environment drives tumor progression invivo. Proc Natl Acad Sci U S A (2001) 1.11
Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study. Am J Pathol (1984) 1.09
Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab Invest (1985) 1.09
Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ (1999) 1.08
Choline-deficiency fatty liver: impaired release of hepatic triglycerides. J Lipid Res (1968) 1.08
Nonrandom nature of in vivo methylation of dimethylnitrosamine and the subsequent removal of methylated products from rat liver chromatin DNA. Cancer Res (1976) 1.06
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat. Cancer Res (1985) 1.02
5-azacytidine potentiates initiation induced by carcinogens in rat liver. Carcinogenesis (1985) 1.01
Interleukin (IL)-6 and receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis. Scand J Rheumatol (2008) 0.99
Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers. Lancet (1985) 0.99
Cell deletion by apoptosis during regression of renal hyperplasia. Am J Pathol (1989) 0.98
Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis (1995) 0.97
Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. Carcinogenesis (1995) 0.97
Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage. Gastroenterology (1978) 0.97
The influence of tryptophan on hepatic polyribosomes and protein synthesis in fasted mice. Biochem Biophys Res Commun (1967) 0.97
Non-random nature of in vivo interaction of 3H-N-hydroxy-2-acetylaminofluorene and its subsequent removal from rat liver chromatin-DNA. Chem Biol Interact (1976) 0.97
Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy. Exp Mol Pathol (1986) 0.97
Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci. Carcinogenesis (1990) 0.96
Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens. Cancer Res (1987) 0.96
Distinctive biochemical pattern associated with resistance of hepatocytes in hepatocyte nodules during liver carcinogenesis. Environ Health Perspect (1983) 0.94
Compartmental syndrome due to viper bite. Arch Orthop Trauma Surg (1991) 0.94
Restoration of serum albumin levels in nagase analbuminemic rats by hepatocyte transplantation. Hepatology (1999) 0.93
Sequential alterations in growth control and cell dynamics of rat hepatocytes in early precancerous steps in hepatocarcinogenesis. Cancer Res (1986) 0.93
Role of thyroid hormone in stimulating liver repopulation in the rat by transplanted hepatocytes. Hepatology (1999) 0.91
Differences in the steady-state levels of c-fos, c-jun and c-myc messenger RNA during mitogen-induced liver growth and compensatory regeneration. Hepatology (1993) 0.91
Total and HDL cholesterol in human hematologic neoplasms. Int J Hematol (1991) 0.90
Liver cell proliferation induced by a single dose of lead nitrate. Am J Pathol (1983) 0.89
Synthesis and fragmentation of DNA in phytohaemagglutinin-stimulated human peripheral blood lymphocytes. Immunol Commun (1973) 0.89
Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control. Diabetes Care (1997) 0.89
Studies on carcinogen chromatin--DNA interaction: inhibition of N-methyl-N-nitrosourea-induced methylation of chromatin--DNA by spermine and distamycin A. Biochemistry (1978) 0.89
Sexually differentiated response to choline in choline deficiency and ethionine intoxication. Int J Exp Pathol (1995) 0.88
Liver hyperplasia is not necessarily associated with increased expression of c-fos and c-myc mRNA. Carcinogenesis (1990) 0.87
Variations of serum lipoproteins during cell proliferation induced by lead nitrate. Exp Mol Pathol (1989) 0.87
Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B. Gut (1979) 0.87
Serum lipoprotein pattern as modified in G6PD-deficient children during haemolytic anaemia induced by fava bean ingestion. Int J Exp Pathol (1992) 0.86
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells. Biochem J (1997) 0.86
Dietary orotic acid, a new selective growth stimulus for carcinogen altered hepatocytes in rat. Cancer Lett (1982) 0.86
Choline enhances acetylaminofluorene promotion of liver carcinogenesis in female but not in male rats. Carcinogenesis (1992) 0.86
Acinar cell carcinoma of rat pancreas: regulation of cholesterol esterification. Br J Cancer (1986) 0.86
Dietary orotic acid enhances the incidence of gamma-glutamyltransferase positive foci in rat liver induced by chemical carcinogens. Carcinogenesis (1983) 0.84
Chemical carcinogenesis: the liver as a model. Pathol Immunopathol Res (1986) 0.84
Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens. Carcinogenesis (1989) 0.84
Evidence for a direct interaction of L-ascorbate with rat liver DNA. Biochim Biophys Acta (1981) 0.84
Changes in serum and hepatic cholesterol in lead-induced liver hyperplasia. Toxicol Pathol (1984) 0.83
Cholesterol and phospholipid composition of mitochondria and microsomes isolated from morris hepatoma 5123 and rat liver. FEBS Lett (1973) 0.83
Sexual dimorphism in the regulation of cell turnover during liver hyperplasia. Chem Biol Interact (1995) 0.83
Cell proliferation in rat kidney induced by 1,2-dibromoethane. Toxicol Lett (1987) 0.83
Severe hypertrophic cardiomyopathy in an infant of a diabetic mother. Diabetes Care (1997) 0.83
Repair of rat liver DNA in vivo damaged by ethylene dibromide. Biochem Pharmacol (1977) 0.83
Labelling of liver and plasma lecithins after injection of 1-2-14C-2-demethylaminoethanol and 14C-L-methionine-methyl to choline deficient rats. Lipids (1969) 0.83
Patterns of damage and repair of liver DNA induced by carcinogenic methylating agents in vivo. Cancer Res (1973) 0.82
Studies on hypomethylation of liver DNA during early stages of chemical carcinogenesis in rat liver. Carcinogenesis (1989) 0.82
Resistance to hepatotoxins acquired by hepatocytes during liver regeneration. Cancer Res (1983) 0.82
Transient inhibition by orotic acid does not abolish the in vivo response of rat hepatocytes to a direct mitogen, lead nitrate. J Hepatol (1997) 0.82
Effect of tryptophan on polyribosomes and protein synthesis in liver. Am J Clin Nutr (1971) 0.82
The enhancing effect of fasting/refeeding on the growth of nodules selectable by the resistant hepatocyte model in rat liver. Carcinogenesis (1995) 0.81
Different effects of regenerative and direct mitogenic stimuli on the growth of initiated cells in the resistant hepatocyte model. Jpn J Cancer Res (1993) 0.81
The resistance phenotype in the development and treatment of cancer. Lancet Oncol (2000) 0.81
Effect of fasting/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat. Carcinogenesis (1999) 0.81
Measurement of Z boson production in Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV with the ATLAS detector. Phys Rev Lett (2013) 0.81
Protein kinase C isozyme pattern in liver hyperplasia. Biochem Biophys Res Commun (1994) 0.81
Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Eur J Epidemiol (1992) 0.81
Chronic mitoinhibition during promotion of hepatocarcinogenesis. Dig Dis Sci (1991) 0.80